A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)

NCT00741104 · clinicaltrials.gov ↗

COMPLETED

Status

363

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Infliximab

Sponsor

Merck Sharp & Dohme LLC